Marqibo

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2009-2016
01220092016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
BACKGROUND Vincristine sulfate liposome injection (VSLI; Marqibo®) is an encapsulated preparation of standard vincristine in… (More)
  • table I
  • table III
  • table III
  • table IV
  • figure 1
Is this relevant?
2014
2014
BACKGROUND VSLI (Marqibo) is active in advanced non-Hodgkin lymphoma (NHL) and untreated aggressive NHL. Because of its favorable… (More)
  • table 1
  • table 2
  • table 5
  • table 3
  • figure 1
Is this relevant?
2011
2011
Marqibo (vincristine sulfate liposome injection, VSLI) is a novel liposomal formulation of vincristine sulfate (VCR) being… (More)
  • table I
  • table II
  • table III
  • table IV
Is this relevant?
2011
2011
6527 Background: In a phase II, multi-national study (RALLY Trial; NCT00495079 ), 65 adults (median age 32 yrs, range 19 to 83… (More)
Is this relevant?
Review
2009
Review
2009
BACKGROUND Marqibo, a sphingosomal/cholesterol encapsulation of vincristine sulfate has targeted, increased, and sustained… (More)
Is this relevant?
2009
2009
9067 Background: Preclinical and clinical studies showed that liposomal encapsulation of vincristine sulfate (VCR) results in… (More)
Is this relevant?